Pfizer B7471014

Pfizer B7471014

Pfizer B7471014                Started: 11/2020 Study Name: A phase 3, single-arm trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy children 15 months through 17 years of age Indication: Pneumococcal Principal...
Forte Biosciences FB401-01

Forte Biosciences FB401-01

Started: 11/2020 Study Name: A randomized, double-blind, placebo-controlled, multicenter, 16-week trial to evaluate the efficacy and safety of xxx in children, adolescent and adult subjects (ages 2 years and older) with mild to moderate atopic dermatitis Indication:...
Pfizer B7471014

Pfizer C3671008

Started: 3/2020 Study name: A phase 3, randomized, double- or observer-blinded, placebo-controlled trial to evaluate the efficacy and safety of a respiratory syncytial virus (rsv) perfusion subunit vaccine in infants born to women vaccinated during pregnancy...
Pfizer B7471014

Pfizer B7471011

Started: 2/2020 Study name: A phase 3, randomized, double-blind trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy infants Indication: Pneumococcal Principal Investigators: Brad Brabec, Dave...
Sanofi Pasteur MET59

Sanofi Pasteur MET59

Started: 9/2019 Study Name: Immunogenicity and Safety of a Booster Dose of an Investigational xxx Meningococcal Conjugate Vaccine in Adolescents and Adults Indication: Meningitis Principal Investigators: Paul Bernhardson, Brad Brabec, Steve...
Astra Zeneca Melody D5290C00004

Astra Zeneca Melody D5290C00004

Started: 9/2019 Study Name: A phase 3 randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of xxx, a monoclonal antibody with an extended half-life against respiratory syncytial virus, in healthy late preterm and term infants (melody)...